C7-substituted quinazolinone and dihydroquinazolinone inhibitors of p38 map kinase.

被引：0
|
作者：
Bao, JM
Miao, SW
Rupprech, KM
Pivnichny, JV
Zaller, DM
Shoop, WL
O'Neill, EA
O'Keefe, SJ
Thompson, CM
Cubbon, RM
Wang, RX
Zhang, WX
Thompson, JE
Doherty, JB
机构：
[1] Merck & Co Inc, Med Chem, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Dept Med Chem, Rahway, NJ 07065 USA
[3] Merck & Co Inc, Dept Inflammat Rheumatol, Rahway, NJ 07065 USA
[4] Merck & Co Inc, Dept Immunol, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
129-MEDI
引用
收藏
页码：U130 / U130
页数：1
相关论文
共 50 条
  • [1] Novel inhibitors of p38 MAP kinase.
    Shetty, R
    Moffett, KK
    Nguyen, D
    Kelly, MJ
    Michelotti, EL
    Dorsey, BD
    Springman, E
    Bukhtiyarova, M
    Northrop, K
    Chai, XM
    Saporito, MS
    Ochman, AR
    Karpusas, M
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [2] Allosteric and slow binding inhibitors of p38 MAP kinase.
    Regan, J
    Breitfelder, S
    Cirillo, P
    Gilmore, T
    Graham, A
    Hickey, E
    Madwed, J
    Moriak, M
    Moss, N
    Pargellis, C
    Proto, A
    Tong, L
    Torcellini, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U683 - U683
  • [3] Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase
    Stelmach, JE
    Liu, LP
    Patela, SB
    Pivnichny, JV
    Scapin, G
    Singh, S
    Hop, CECA
    Wang, Z
    Strauss, JR
    Cameron, PM
    Nichols, EA
    O'Keefe, SJ
    O'Neill, EA
    Schmatz, DM
    Schwartz, CD
    Thompson, CM
    Zaller, DM
    Doherty, JB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) : 277 - 280
  • [4] Discovery and design of novel benzimidazolone as inhibitors of p38 MAP kinase.
    Hammach, A
    Ralph, M
    Corbo, F
    Barbosa, A
    Liu, PR
    Soleymanzadeh, F
    Goldberg, D
    Sarko, C
    Mckibben, B
    Moss, N
    Hao, MH
    White, A
    Qian, K
    Pargellis, C
    Kroe, R
    Wildeson, J
    Nelson, R
    Fadra, T
    Capolino, A
    Kashem, M
    Patnaude, L
    Madwed, J
    Torcellini, C
    Kaplita, P
    Farrel, T
    Hu, HB
    Yazdania, M
    Kavanaugh, K
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [5] 4-azaindoles: Novel inhibitors of p38 MAP kinase.
    Trejo, A
    Arzeno, H
    Browner, M
    Cheng, SA
    Corner, DD
    Dalrymple, S
    Freire-Moar, J
    Lim, J
    Mcintosh, J
    Miller, J
    Myers, PL
    Saunders, J
    Sjogren, EB
    Spellmyer, D
    Warren, SD
    Whiteley, PE
    Zeng, L
    Goldstein, DM
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U59 - U59
  • [6] Substituted isoxazoles as potent inhibitors of p38 MAP kinase
    Laufer, Stefan A.
    Margutti, Simona
    Fritz, Martina D.
    [J]. CHEMMEDCHEM, 2006, 1 (02) : 197 - 207
  • [7] Inhibitors of p38α MAP kinase
    Chakravarty, S
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 177 - 186
  • [8] PRK, a novel protein kinase regulated by the p38 MAP kinase.
    New, T
    Jiang, Y
    Zhao, M
    Liu, K
    Flood, L
    Kato, Y
    Parry, G
    Han, J
    [J]. FASEB JOURNAL, 1998, 12 (04): : A448 - A448
  • [9] Potent inhibitors of the map kinase p38
    Henry, JR
    Rupert, KC
    Dodd, JH
    Turchi, IJ
    Wadsworth, SA
    Cavender, DE
    Schafer, PH
    Siekierka, JJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
  • [10] The development p38 MAP kinase inhibitors
    Hynes, John
    Wu, H.
    Dyckman, A. J.
    Lin, S.
    Wrobleski, S. T.
    Gillooly, K. M.
    McIntyre, K. W.
    Pitt, S.
    Shen, D. R.
    Shuster, D. J.
    Xia, X.
    Zhang, R.
    [J]. INFLAMMATION RESEARCH, 2007, 56 : S474 - S474
12345